These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37831046)

  • 1. Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men.
    Ramu B; Cogswell R; Ravichandran AK; Cleveland J; Mehra MR; Goldstein D; Uriel N; Dirckx N; Ahmed S; Yuzefpolskaya M
    JACC Heart Fail; 2023 Dec; 11(12):1692-1704. PubMed ID: 37831046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
    Mehra MR; Uriel N; Naka Y; Cleveland JC; Yuzefpolskaya M; Salerno CT; Walsh MN; Milano CA; Patel CB; Hutchins SW; Ransom J; Ewald GA; Itoh A; Raval NY; Silvestry SC; Cogswell R; John R; Bhimaraj A; Bruckner BA; Lowes BD; Um JY; Jeevanandam V; Sayer G; Mangi AA; Molina EJ; Sheikh F; Aaronson K; Pagani FD; Cotts WG; Tatooles AJ; Babu A; Chomsky D; Katz JN; Tessmann PB; Dean D; Krishnamoorthy A; Chuang J; Topuria I; Sood P; Goldstein DJ;
    N Engl J Med; 2019 Apr; 380(17):1618-1627. PubMed ID: 30883052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
    Mehra MR; Goldstein DJ; Uriel N; Cleveland JC; Yuzefpolskaya M; Salerno C; Walsh MN; Milano CA; Patel CB; Ewald GA; Itoh A; Dean D; Krishnamoorthy A; Cotts WG; Tatooles AJ; Jorde UP; Bruckner BA; Estep JD; Jeevanandam V; Sayer G; Horstmanshof D; Long JW; Gulati S; Skipper ER; O'Connell JB; Heatley G; Sood P; Naka Y;
    N Engl J Med; 2018 Apr; 378(15):1386-1395. PubMed ID: 29526139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
    Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J; Ransom J; Bansal A; Takeda K; Agarwal R; Byku M; Givertz MM; Bitar A; Hall S; Zimpfer D; Vega JD; Kanwar MK; Saeed O; Goldstein DJ; Cogswell R; Sheikh FH; Danter M; Pya Y; Phancao A; Henderson J; Crandall DL; Sundareswaran K; Soltesz E; Estep JD;
    JAMA; 2023 Dec; 330(22):2171-2181. PubMed ID: 37950897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
    John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    Nayak A; Hall SA; Uriel N; Goldstein DJ; Cleveland JC; Cowger JA; Salerno CT; Naka Y; Horstmanshof D; Crandall D; Wang A; Mehra MR
    J Am Coll Cardiol; 2023 Aug; 82(9):771-781. PubMed ID: 37612008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study.
    Saeed O; Colombo PC; Mehra MR; Uriel N; Goldstein DJ; Cleveland J; Connors JM; Najjar SS; Mokadam NA; Bansal A; Crandall DL; Sood P; Jorde UP
    J Heart Lung Transplant; 2020 Jun; 39(6):518-525. PubMed ID: 32340871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device.
    Mehra MR; Nayak A; Morris AA; Lanfear DE; Nemeh H; Desai S; Bansal A; Guerrero-Miranda C; Hall S; Cleveland JC; Goldstein DJ; Uriel N; Chen L; Bailey S; Anyanwu A; Heatley G; Chuang J; Estep JD
    JACC Heart Fail; 2022 Dec; 10(12):948-959. PubMed ID: 36456068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.
    Steinberg RS; Okoh AK; Wang J; Patel KJ; Gangavelli A; Nayak A; Ko YA; Gupta D; Daneshmand M; Vega JD; Morris AA
    JACC Heart Fail; 2024 Aug; 12(8):1459-1469. PubMed ID: 38180429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.
    Netuka I; Sood P; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Marasco S; Beyersdorf F; Damme L; Schmitto JD
    J Am Coll Cardiol; 2015 Dec; 66(23):2579-2589. PubMed ID: 26670056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.